Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Forte Biosciences, Inc. (TOCA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
SC 13D/A
| Wagner Paul A. reports a 5.2% stake in Forte Biosciences, Inc. |
| 08/10/2023 |
SC 13D/A
| ATG Fund II LLC reports a 4% stake in Forte Biosciences, Inc. |
| 08/03/2023 |
SC 13D/A
| Camac Fund, LP reports a 3.6% stake in Forte Biosciences Inc. |
| 07/06/2023 |
SC 13D/A
| Funicular Funds, LP reports a 9.6% stake in Forte Biosciences, Inc. |
| 07/05/2023 |
SC 13D/A
| Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc. |
| 05/25/2023 |
SC 13D/A
| Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc. |
| 03/29/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/21/2023 |
SC 13D/A
| Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc. |
| 09/28/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/22/2022 |
SC 13D/A
| Funicular Funds, LP reports a 10% stake in Forte Biosciences, Inc. |
| 08/24/2022 |
SC 13D/A
| Funicular Funds, LP reports a 8% stake in Forte Biosciences, Inc. |
| 08/18/2022 |
SC 13D/A
| Camac Fund, LP reports a 7.1% stake in Forte Biosciences Inc. |
| 08/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/08/2022 |
SC 13D/A
| Camac Fund, LP reports a 9.8% stake in Forte Biosciences, Inc. |
| 07/19/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/16/2021 |
SC 13D/A
| Wagner Paul A. reports a 9.1% stake in Forte Biosciences, Inc. |
|
|